整形外科インプラント - 世界市場の考察、競合情勢、市場予測（2030年）

世界の整形外科インプラントの市場規模は、2024年～2030年の予測期間にCAGRで5.46％の成長が見込まれます。市場は、関節炎、骨粗しょう症などの整形外科疾患の有病率の増加、老年人口の負担の増加、交通事故やその他の負傷の増加、整形外科インプラントの安全性、入手性、使いやすさの向上への注目の高まりなどの要因によって活況が見込まれ、予測期間（2024年～2030年）に市場における大きな収益成長が見込まれます。

整形外科インプラントの市場力学

世界保健機関（WHO）（2022）によると、筋骨格系疾患は障害の主因であり、世界中で約17億1,000万人が骨粗しょう症、変形性関節症、関節リウマチなどの筋骨格系疾患に苦しんでいます。

変形性関節症は、退行性関節炎または磨耗性関節炎としても知られ、関節に影響を及ぼし、時間の経過とともに骨の表面から滑らかな軟骨がすり減ります。これにより、患者は関節の炎症、腫れ、痛みに直面し、人の全体的な動きに影響を及ぼします。重症の場合、患者は整形外科インプラント手術を受けなければならません。

世界保健機関（WHO）によると、2019年に世界で約5億2,800万人が変形性関節症を患っていました。同じ資料によると、2019年に世界中で1,800万人が関節リウマチに罹患していました。

また、上記の資料によると、2019年に変形性関節症は1,900万YLD（years lived with disability）に寄与し、関節リウマチは世界で240万YLDに寄与しました。

交通事故の増加も整形外科インプラント市場の成長を促進する大きな要因です。突発的な交通事故による軽傷や致命傷は、時に障害につながり、整形外科インプラントの必要性を高め、整形外科インプラント市場の成長にプラスの影響を与えています。WHO（2022）によると、毎年約130万人が交通事故が原因で死亡し、約2,000万～5,000万人が致命的でない怪我や何らかの障害を負っています。

しかし、手術の高いコストに加え、再手術を受ける必要性や整形外科インプラントの厳しい規制承認が、整形外科インプラント市場の成長抑制要因として作用する可能性があります。

COVID-19パンデミックは整形外科インプラント市場に若干の影響を与えています。パンデミックの発生により、外来受診がキャンセルされ、緊急性のない病院や処置が中止されました。その結果、整形外科の検査や処置が減少しました。経済協力開発機構（OECD）の統計（2023）によると、人工股関節置換術の件数は、2019年と比較して、2020年にアイルランドとイタリアで20％近く減少し、ノルウェーとチェコでは10％以上の減少が見られました。また、COVID-19パンデミック期間に整形外科インプラントの製造、輸出入、その他の関連活動が阻害されました。しかし、COVID-19のワクチン開発により、ロックダウン規制が緩和され、経済情勢が正常化したことで、外来受診などの通常の医療サービスが再開され、整形外科インプラント市場の製品需要が軌道に乗るなど、経済回復のプロセスが始まっています。

整形外科インプラント市場のセグメント分析

整形外科インプラントの製品タイプセグメントでは、膝関節インプラントカテゴリが予測期間（2024年～2030年）に市場全体で大きな収益成長を記録する見込みです。

膝関節インプラントは、骨の疾患や怪我による痛みを軽減する傾向があり、膝の注射、抗炎症薬などの非手術治療よりも患者に十分な救済を提供します。

人工膝関節置換術後の患者は、痛み、可動性、QOL（生活の質）の向上を見せます。日常生活に支障なく戻ることができます。

2022年の経済協力開発機構（OECD）の統計によると、2019年に人口10万人当たり、スイスで約260件、ドイツで227件、オーストラリアで211件、韓国で153件、英国で142件の人工膝関節置換術が行われました。同資料によると、2019年における人工膝関節置換術の平均は人口10万人当たり137件でした。インプラントの材料、デザイン、手術技法における新技術の進歩は、膝関節インプラントの寿命を約10～15年延ばすのに役立っています。

当レポートでは、世界の整形外科インプラント市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 整形外科インプラント市場レポートのイントロダクション

第2章 整形外科インプラント市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 整形外科インプラント市場の主な要因の分析

• 整形外科インプラント市場の促進要因
• 整形外科インプラント市場の抑制要因と課題
• 整形外科インプラント市場の機会

第5章 整形外科インプラント市場のポーターのファイブフォース分析

第6章 整形外科インプラント市場に対するCOVID-19の影響分析

第7章 整形外科インプラント市場のレイアウト

• 製品タイプ
  • 股関節インプラント
  • 膝関節インプラント
  • 脊椎インプラント
  • 足、足首インプラント
  • その他
• エンドユーザー別
  • 病院
  • 整形外科クリニック
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 整形外科インプラント市場の企業と製品のプロファイル

• Zimmer Biomet
• Stryker
• Johnson & Johnson Services, Inc.
• Biotek (Chetan Meditech Pvt. Ltd.)
• CONMED Corporation
• Medtronic
• Enovis
• Smith+Nephew
• B. Braun SE
• Exactech, Inc.
• Corin Group
• Conformis
• Medacta International
• Globus Medical
• Arthrex, Inc.
• Meril Life Sciences Pvt. Ltd.
• Auxein Medical
• United Orthopedic Corporation
• Limacorporate S.p.A.
• NuVasive®, Inc.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Orthopedic Implants Market
• Table 3: Orthopedic Implants Market in Global (2021-2030)
• Table 4: Orthopedic Implants Market in Global by Product Type (2021-2030)
• Table 5: Orthopedic Implants Market in Global by End-User (2021-2030)
• Table 6: Orthopedic Implants Market in Global by Geography (2021-2030)
• Table 7: Orthopedic Implants Market in North America (2021-2030)
• Table 8: Orthopedic Implants Market in North America by Country (2021-2030)
• Table 9: Orthopedic Implants Market in the US (2021-2030)
• Table 10: Orthopedic Implants Market in Canada (2021-2030)
• Table 11: Orthopedic Implants Market in Mexico (2021-2030)
• Table 12: Orthopedic Implants Market in Europe (2021-2030)
• Table 13: Orthopedic Implants Market in Europe by Country (2021-2030)
• Table 14: Orthopedic Implants Market in France (2021-2030)
• Table 15: Orthopedic Implants Market in Germany (2021-2030)
• Table 16: Orthopedic Implants Market in the United Kingdom (2021-2030)
• Table 17: Orthopedic Implants Market in Italy (2021-2030)
• Table 18: Orthopedic Implants Market in Spain (2021-2030)
• Table 19: Orthopedic Implants Market in the Rest of Europe (2021-2030)
• Table 20: Orthopedic Implants Market in APAC (2021-2030)
• Table 21: Orthopedic Implants Market in APAC by Country (2021-2030)
• Table 22: Orthopedic Implants Market in China (2021-2030)
• Table 23: Orthopedic Implants Market in Japan (2021-2030)
• Table 24: Orthopedic Implants Market in India (2021-2030)
• Table 25: Orthopedic Implants Market in Australia (2021-2030)
• Table 26: Orthopedic Implants Market in South Korea (2021-2030)
• Table 27: Orthopedic Implants Market in Rest of APAC (2021-2030)
• Table 28: Orthopedic Implants Market in the Rest of the World (2021-2030)
• Table 29: Orthopedic Implants Market in RoW by Region (2021-2030)
• Table 30: Orthopedic Implants Market in the Middle East (2021-2030)
• Table 31: Orthopedic Implants Market in Africa (2021-2030)
• Table 32: Orthopedic Implants Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Orthopedic Implants Market
• Figure 3: Orthopedic Implants Market in Global (2021-2030)
• Figure 4: Orthopedic Implants Market in Global by Product Type (2021-2030)
• Figure 5: Orthopedic Implants Market in Global by End-User (2021-2030)
• Figure 6: Orthopedic Implants Market in Global by Geography (2021-2030)
• Figure 7: Orthopedic Implants Market in North America (2021-2030)
• Figure 8: Orthopedic Implants Market in North America by Country (2021-2030)
• Figure 9: Orthopedic Implants Market in the US (2021-2030)
• Figure 10: Orthopedic Implants Market in Canada (2021-2030)
• Figure 11: Orthopedic Implants Market in Mexico (2021-2030)
• Figure 12: Orthopedic Implants Market in Europe (2021-2030)
• Figure 13: Orthopedic Implants Market in Europe by Country (2021-2030)
• Figure 14: Orthopedic Implants Market in France (2021-2030)
• Figure 15: Orthopedic Implants Market in Germany (2021-2030)
• Figure 16: Orthopedic Implants Market in the United Kingdom (2021-2030)
• Figure 17: Orthopedic Implants Market in Italy (2021-2030)
• Figure 18: Orthopedic Implants Market in Spain (2021-2030)
• Figure 19: Orthopedic Implants Market in the Rest of Europe (2021-2030)
• Figure 20: Orthopedic Implants Market in APAC (2021-2030)
• Figure 21: Orthopedic Implants Market in APAC by Country (2021-2030)
• Figure 22: Orthopedic Implants Market in China (2021-2030)
• Figure 23: Orthopedic Implants Market in Japan (2021-2030)
• Figure 24: Orthopedic Implants Market in India (2021-2030)
• Figure 25: Orthopedic Implants Market in Australia (2021-2030)
• Figure 26: Orthopedic Implants Market in South Korea (2021-2030)
• Figure 27: Orthopedic Implants Market in Rest of APAC (2021-2030)
• Figure 28: Orthopedic Implants Market in the Rest of the World (2021-2030)
• Figure 29: Orthopedic Implants Market in RoW by Region (2021-2030)
• Figure 30: Orthopedic Implants Market in the Middle East (2021-2030)
• Figure 31: Orthopedic Implants Market in Africa (2021-2030)
• Figure 32: Orthopedic Implants Market in South America (2021-2030)
• Figure 33: Market Drivers
• Figure 34: Market Barriers
• Figure 35: Marker Opportunities
• Figure 36: PORTER'S Five Force Analysis

Orthopedic Implants Market By Product Type (Hip Implants, Knee Implants, Spinal Implants, Foot And Ankle Implants, And Others), By End-User (Hospitals, Orthopedic Clinics, And Others ), by geography is estimated to register growth at a remarkable CAGR forecast during 2024-2030 owing to increasing prevalence of orthopedic diseases and rising demand for personalized orthopedic implants

The global orthopedic implants market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030. The orthopedic implants market is slated to witness prosperity owing to factors such as the increasing prevalence of orthopedic diseases such as arthritis, osteoporosis, and others, a growing burden of the geriatric population, the rising number of road accidents associated and other injuries, and the growing focus on improving the safety, affordability, and usability of orthopedic implants for people are further expected to result in the appreciable revenue growth in the orthopedic implants market during the forecast period (2024-2030).

Orthopedic Implants Market Dynamics:

According to World Health Organization (WHO) 2022, musculoskeletal conditions are the leading contributor to disability, and worldwide around 1.71 billion people are suffering from musculoskeletal diseases such as osteoporosis, osteoarthritis, rheumatoid arthritis, and others.

Osteoarthritis also known as degenerative or wear-and-tear arthritis affects the joints and with time leads to the wearing off of smooth cartilage from the surface of bones. This causes patients to face inflammation, swelling, and pain in joints affecting the overall movement of a person. In severe cases, patients have to undergo orthopedic implant surgery.

According to World Health Organization 2022, worldwide around 528 million people suffered from osteoarthritis in 2019. As per the same source, worldwide 18 million people had rheumatoid arthritis in 2019.

Also, according to the above-mentioned source osteoarthritis contributed to 19 million years lived with disability (YLDs), while rheumatoid arthritis contributed to 2.4 million YLDs globally in 2019.

The rise in road traffic accidents is another major factor driving the growth of the orthopedic implants market. Light and fatal injuries owing to sudden road accidents lead to disability sometimes and increase the need for orthopedic implants, positively impacting the growth of the orthopedic implants market. According to WHO 2022, approximately 1.3 million people die each year because of road traffic accidents and around 20-50 million individuals suffer from non-fatal injuries or some sort of disability.

However, the high cost of the procedure coupled with the need to undergo revision surgery and stringent regulatory approval for orthopedic implants may act as a restraint in the market growth for orthopedic implants.

The COVID-19 pandemic has slightly impacted the market for orthopedic implants. The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. This resulted in a reduced number of orthopedic examinations and procedures. As per Organization for Economic Cooperation and Development (OECD) statistics (2023), a nearly 20% drop in hip replacements was observed in 2020 in Ireland and Italy, and a more than 10% drop in Norway and the Czech Republic compared to 2019. Also, the manufacturing, import, export, and other related activities of orthopedic implants were hampered during the period of COVID- 19 pandemic. However, the vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatients visits, thereby bringing the demand for products on track in the orthopedic implants market.

Orthopedic Implants Market Segment Analysis:

Orthopedic Implants Market by Product Type (Hip Implants, Knee Implants, Spinal Implants, Foot and Ankle Implants, and Others), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Based on the product type segment of orthopedic implants, the knee implants category is projected to register a significant growth in revenue in the overall orthopedic implants market during the forecast period (2024-2030).

Knee implants tend to reduce the pain due to any bone disease or injury and provide adequate relief to the patient over non-operative treatments such as knee injections, anti-inflammatory medications, and others.

Post-knee implantation patients witness improvements in pain, mobility, and quality of life. They can return to doing day-to-day tasks without much hindrance.

As per Organization for Economic Cooperation and Development (OECD) statistics for 2022, about 260 knee replacement surgeries in Switzerland, 227 in Germany, 211 in Australia, 153 in Korea, and 142 in the United Kingdom, per 100,000 population were performed in 2019. As per the same source, the average for knee replacement surgery was 137 per 100,000 population in 2019. The newer technological advancements in implant material, design, and surgical technique have facilitated in increasing the longevity of knee implants by about 10-15 years.

Thereby, considering the growing demand for this product type, numerous new products are being developed and launched in the market. For example, in November 2022, Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, obtained 510(k) clearance from the US Food and Drug Administration to market the TriVerse(TM) primary knee system.

Therefore, considering the advantages associated with knee implants and their growing popularity, this product category is expected to generate considerable revenue thereby pushing the overall growth of the global orthopedic implants market during the forecast period.

North America is expected to dominate the overall Orthopedic Implants Market:

Among all the regions, North America is expected to lead in revenue generation in the global orthopedic implants market. This can be due to factors including the prevalence of chronic bone diseases, the increasing old age population, and the presence of key companies involved in the production of orthopedic implants, high-tech medical facilities, and others.

One of the prominent factors supporting the growth of the North America orthopedic implants market is the prevalence of chronic bone diseases leading to disability, majorly in the United States. The rising prevalence of arthritis in the US is the major factor responsible for the growth of the orthopedic implants market in the region. As per the Centers for Disease Control and Prevention (CDC) 2022, it has been estimated that there will be around 78.4 million people suffering from doctor-diagnosed arthritis by 2040, and out of that two-thirds will be the women population.

As per the same source, an estimated 34.6 million adults will face arthritis-attributable activity limitations in the US by 2040. As per Arthritis Foundation 2022, around 1.5 million people have rheumatoid arthritis in the United States.

The increasing age makes one susceptible to several health issues including bone diseases, and others, and thus is another driver for the growth of the orthopedic implants market. According to CDC 2022, around 54.1 million US adults were aged 65 or older in 2019. As per the same source, it has been estimated that by 2060, this number will reach up to 94.7 million in the US. Along with the presence of a large patient pool in the country, the increasing focus of manufacturers on launching new products in the market is expected to bolster the growth of the orthopedic implants market in the United States during the forecast period.

For example, in February 2020, In2Bones Global, Inc. received the US Food and Drug Administration clearance to market the Quantum(TM) Total Ankle Replacement System. Therefore, the above-mentioned factors are expected to bolster the growth of the orthopedic implants market in the United States during the forecast period.

Orthopedic Implants Market Key Players:

Some of the key market players operating in the orthopedic implants market include Smith+Nephew, Stryker, Zimmer Biomet, Johnson & Johnson Services, Inc.Biotek (Chetan Meditech Pvt. Ltd.), CONMED Corporation, Medtronic, Enovis, B. Braun SE, Corin Group, Exactech, Inc., Meril Life Sciences Pvt. Ltd., Arthrex, Inc., Conformis, Medacta International, Globus Medical, Auxein Medical, United Orthopedic Corporation, Limacorporate S.p.A., NuVasive®, Inc., and others.

Recent Developmental Activities in the Orthopedic Implants Market:

In September 2022, Zimmer Biomet Holdings, Inc., a global medical technology leader, received the US Food and Drug Administration (FDA) 510(k) clearance of the Identity(TM) Shoulder System for anatomic, reverse, and revision shoulder replacement.

In September 2022, Tyber Medical, LLC, a leading orthopedic device manufacturer providing private-label ORTHOPEDIC Implants for the trauma, extremity, and spine markets, received its second and largest US FDA 510(k) clearance for its expanded line of anatomical plating systems.

In July 2020, Orthofix Medical Inc., a global medical device company focused on musculoskeletal healing products received the US FDA 510(k) clearance and European CE Mark approval for the JuniOrtho® Plating System which is designed to address the demands of advanced deformity and trauma reconstruction of the lower extremities.

Key Takeaways from the Orthopedic Implants Market Report Study

Market size analysis for current orthopedic implants market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the orthopedic implant market.

Top key product developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years

Key companies dominating the global orthopedic implants market.

Various opportunities available for the other competitor in the orthopedic implants market space.

What are the top-performing segments in 2023? How these segments will perform in 2027?

Which are the top-performing regions and countries in the current orthopedic implants market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for orthopedic implants market growth in the coming future?

Target Audience who can be benefited from this Orthopedic Implants Market Report Study

Orthopedic implants products providers

Research organizations and consulting companies

Orthopedic Implants -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in orthopedic implants

Various distribution channels who want to know more about the orthopedic implants market and the latest product innovations in the orthopedic Implants market.

Frequently Asked Questions for the Orthopedic Implants Market:

1. What are orthopedic implants?

Orthopedic implants are intended for the replacement of a joint, bone, or cartilage owing to some damage or deformity that happened due to any disease or injury and include knee, shoulder, hip, foot, and ankle implants among others.

2. What is the market for global orthopedic Implants?

The global orthopedic implants market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030.

3. What are the drivers for the global orthopedic implants market?

The orthopedic implants market is slated to witness prosperity owing to factors such as the increasing prevalence of orthopedic diseases, rising cases of road accidents and other traumatic injuries, the growing burden of the geriatric population, increasing demand for personalized orthopedic implants, rising technological advancements, and the growing focus on improving the safety and usability of orthopedic implants for people are further expected to result in the appreciable revenue growth in the orthopedic implants market during the forecast period (2024-2030).

4. Who are the key players operating in the global orthopedic implants market?

Some of the key market players operating in the orthopedic implants market include Smith+Nephew, Stryker, Zimmer Biomet, Johnson & Johnson Services, Inc.Biotek (Chetan Meditech Pvt. Ltd.), CONMED Corporation, Medtronic, Enovis, B. Braun SE, Corin Group, Exactech, Inc., Meril Life Sciences Pvt. Ltd., Arthrex, Inc., Conformis, Medacta International, Globus Medical, Auxein Medical, United Orthopedic Corporation, Limacorporate S.p.A., NuVasive®, Inc., and others.

5. Which region has the highest share in the orthopedic implants market?

North America is expected to dominate the overall orthopedic implants market during the forecast period, 2024 to 2030. This can be ascribed to the increasing patient population suffering from orthopedic implants for regular household cleaning and sanitation activities and for maintaining personal hygiene, increasing disposable personal income, and a highly potent market in terms of product development and launches, and the local presence of key market players among other factors in the region.

Table of Contents

1.Orthopedic Implants Market Report Introduction

2. Orthopedic Implants Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Orthopedic Implants Market Key Factors Analysis

• 4.1. Orthopedic Implants Market Drivers
  • 4.1.1. Increasing prevalence of orthopedic diseases
  • 4.1.2. Rising number of road accidents and other traumatic injuries
  • 4.1.3. The growing burden of the geriatric population
• 4.2. Orthopedic Implants Market Restraints and Challenges
  • 4.2.1. High cost of procedures coupled with the need to undergo revision surgery
  • 4.2.2. Stringent regulatory policies for orthopedic implants
• 4.3. Orthopedic Implants Market Opportunities
  • 4.3.1. Increasing demand for personalized orthopedic implants
  • 4.3.2. The growing concept of smart orthopedic implants

5. Orthopedic Implants Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Orthopedic Implants Market

7. Orthopedic Implants Market Layout

• 7.1. By Product Type
  • 7.1.1. Hip Implants
  • 7.1.2. Knee Implants
  • 7.1.3. Spinal Implants
  • 7.1.4. Foot and Ankle Implants
  • 7.1.5. Others
• 7.2. By End-User
  • 7.2.1. Hospitals
  • 7.2.2. Orthopedic Clinics
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.1.2. Canada Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.1.3. Mexico Orthopedic Implants Market in USD million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.2.2. Germany Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.2.3. United Kingdom Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.2.4. Italy Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.2.5. Spain Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.2.6. Rest of Europe Orthopedic Implants Market in USD million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.3.2. Japan Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.3.3. India Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.3.4. Australia Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.3.5. South Korea Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.3.6. Rest of the Asia Pacific Orthopedic Implants Market in USD million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.4.2. Africa Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.4.3. South America Orthopedic Implants Market in USD million (2021-2030)

8. Orthopedic Implants Market Company and Product Profiles

• 8.1. Zimmer Biomet
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Stryker
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Johnson & Johnson Services, Inc.
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Biotek (Chetan Meditech Pvt. Ltd.)
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. CONMED Corporation
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Medtronic
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Enovis
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Smith+Nephew
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. B. Braun SE
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Exactech, Inc.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Corin Group
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Conformis
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Medacta International
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Globus Medical
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Arthrex, Inc.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Meril Life Sciences Pvt. Ltd.
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Auxein Medical
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. United Orthopedic Corporation
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Limacorporate S.p.A.
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. NuVasive®, Inc.
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us